Drug Topics

NOVEMBER 5, 2024

Companies like ShiftRx are using technology to help solve the staffing shortage crisis in health care.

227

227

Pharmacy Is Right For Me

NOVEMBER 4, 2024

Meet Lila, a passionate fourth-year Pharm.D. student at Auburn University Harrison College of Pharmacy. During her APPE rotation with the American Association of Colleges of Pharmacy , Lila opened up about her inspiring journey to find the perfect pharmacy school and how, with the guidance of mentors, she discovered her true “Pharmily.” How did you choose your pharmacy school/college or graduate program?

230

230

Pharmacy Times

NOVEMBER 23, 2024

Intravenous immunoglobulin (IVIG) has proven efficacy in autoimmune neuropathies, with mixed but promising outcomes in severe COVID-19 cases and post-acute sequelae of SARS-CoV-2 infection trials.

171

171

Fierce Healthcare

NOVEMBER 13, 2024

Primary care player Forward is abruptly shutting down its operations, closing its locations and canceling scheduled visits, the company publicly announced Wednesday. | Primary care player Forward is abruptly shutting down its operations, closing its locations and canceling scheduled visits, the company publicly announced Wednesday.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

NOVEMBER 22, 2024

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart disease — the first new treatment for the condition in over five years and the company’s first significant commercial product. The drug, known scientifically as acoramidis, will be sold by BridgeBio under the brand name Attruby.

FDA 129

FDA 129

Fierce Pharma

NOVEMBER 8, 2024

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be in the works from Korea’s Alteogen following a licensing deal worth up to | Alteogen will use its human hyaluronidase hybridization platform to develop a subcutaneous formulation of the blockbuster antibody-drug conjugate.

138

138

pharmaphorum

NOVEMBER 8, 2024

AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities

130

130

Pharmacy Times

NOVEMBER 21, 2024

There were 2 main types of switches, including switching to rituximab subcutaneous and switching among different intravenous rituximab treatments.

156

156

Fierce Healthcare

NOVEMBER 18, 2024

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which tracks sleep, heart rate and activity. | Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring.

143

143

STAT

NOVEMBER 20, 2024

WASHINGTON  — People close to Robert F. Kennedy Jr. are exploring a proposal that could upend how physician payment is determined in America, four sources familiar with the process told STAT.

131

131

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

NOVEMBER 14, 2024

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy has already been approved to treat AADC deficiency in Europe and the U.K., among other countries, where it's branded as Upstaza.

FDA 130

FDA 130

Drug Topics

NOVEMBER 22, 2024

Public health and infectious disease experts offered their perspectives on the 2024 US bird flu outbreak and its potential of becoming a greater public health crisis.

220

220

PharmaVoice

NOVEMBER 11, 2024

Psychiatry is getting more targeted as drugmakers develop a new range of treatments for depression.

126

126

Pharmacy Times

NOVEMBER 27, 2024

In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.

153

153

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

NOVEMBER 14, 2024

Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.

142

142

STAT

NOVEMBER 8, 2024

WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization.

132

132

Fierce Pharma

NOVEMBER 20, 2024

Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are already eying the blockbuster as a potential target. | The spinal muscular atrophy drug is a growth driver for the Swiss pharma giant, prompting the company to prioritize its defense against potential generics.

FDA 124

FDA 124

Drug Topics

NOVEMBER 19, 2024

Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.

218

218

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

NOVEMBER 27, 2024

Pharmaceutical professionals expect digital solutions to solve drug development headaches, with AI already proving disruptive.

122

122

Pharmacy Times

NOVEMBER 1, 2024

ASHP investigators determined the severity and impact of ongoing drug shortages, with approximately 99% of respondents reporting that they experienced a shortage.

158

158

Fierce Healthcare

NOVEMBER 19, 2024

The FDA will hold its first Digital Health Advisory Committee (DHAC) meeting to discuss how the agency should review medical devices that rely on generative AI, like chatbots. | The FDA seeks advice on regulatory challenges it has identified for generative AI used in medical devices, which include uncertainty about the foundation model, hallucinations and the ability to define intended use.

FDA 137

FDA 137

STAT

NOVEMBER 12, 2024

The last time Mark Palinski went to a Narcotics Anonymous meeting, he was asked to leave and never come back. He stills remembers the argument: All he had done was advocate for the use of the “gold standard” treatment opioid addiction, a common medication called buprenorphine.  To Palinski, buprenorphine is a godsend.

144

144

PharmaVoice

NOVEMBER 5, 2024

Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.

124

124

Drug Topics

NOVEMBER 5, 2024

A collection of independent pharmacies was the next in line to file suits against major pharmacy benefit managers for alleged drug price fixing.

Independent Pharmacies 220

Independent Pharmacies 220

pharmaphorum

NOVEMBER 11, 2024

Mass General Brigham researchers have developed an AI that can spot hidden cases of long COVID from electronic health records

120

120

Pharmacy Times

NOVEMBER 18, 2024

The disorder presents as severe lung disease, with lung transplantation as the only current therapeutic option for long-term survival.

FDA 153

FDA 153

Fierce Healthcare

NOVEMBER 19, 2024

More than half of health system and health plan executives say AI is an immediate priority, and 73% are increasing their investments in the technology, a new C-suite survey finds. | More than half of health system and health plan executives say AI is an immediate priority, and 73% are increasing their investments in the technology, a new C-suite survey finds.

137

137

STAT

NOVEMBER 19, 2024

When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife backlash. The drug was based on an active ingredient that had been available for many years at a much lower cost. Confronted with the public outcry, the FDA took an unusual step: It allowed pharmacies to continue making their own copies of the drug through the practice of pharmacy compounding, selling it at a fraction of Makena’s price.

Compounding 128

Compounding FDA 128

Fierce Pharma

NOVEMBER 6, 2024

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a past COVID-19 vaccine supply deal. The Maryland biotech has agreed to pay $123.8 million to end a COVID vaccine supply pact with the U.K.

Vaccines 120

Vaccines 120

Drug Topics

NOVEMBER 4, 2024

Ruth Carrico PhD, DNP, APRN, discussed the importance of annual vaccination and overall health awareness and literacy during the winter flu season.

Vaccines 210

Vaccines 210

The Checkup by Singlecare

NOVEMBER 4, 2024

Diabetes is a medical condition that occurs when your body can’t regulate blood sugar levels. Consistently elevated blood sugar causes health problems, such as heart disease, kidney disease, and nerve damage, particularly in your feet and eyes. Diabetes treatment usually includes medications , such as oral medications, non-insulin injectable medicines, and sometimes insulin , depending on which type of diabetes you have as well as your blood glucose control.

Compounding 93

Compounding People Management Dosage Labelling 93

Pharmacy Times

NOVEMBER 30, 2024

Potential solutions can include international funding, improved primary health care measures, and cost-effective screening methods.

149

149

Fierce Healthcare

NOVEMBER 26, 2024

Mount Sinai Health System has opened the doors of its new AI research center in Manhattan, the Hamilton and Amabel James Center for AI and Human Health. | Mount Sinai Health System announced on Tuesday that it opened its Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which will be a research site for AI development.

128

128